Zeltiq Sees Q4 Sales Above Street, Again Lifts FY Guidance; Stock Up 7%

(RTTNews) - Medical technology company Zeltiq Aesthetics Inc (ZLTQ) on Tuesday said it expects to report fourth-quarter revenues of $51 million to $52 million, compared with $35.8 million last year.

Analysts polled by Thomson Reuters currently expect revenues of $49.64 million for the quarter.

For the full year 2014, the company expects revenues of $175 million to $176 million, up from prior guidance of $171 million to $173 million. In the previous year, Zeltiq reported revenues of $111.6 million.

Analysts expect revenues of $173.3 million for the year.

For the full year 2015, Zeltiq projects revenues of about $230 million, while analysts expect $215.7 million.

Zeltiq Aesthetics is engaged in developing non-invasive products for the selective reduction of fat.

ZLTQ closed Tuesday at $27.90, down $0.97 or 3.36%, on a volume of 1.2 million shares on the Nasdaq. In after hours, the stock gained $2.05 or 7.35% at 29.95%.